Insights into the future of first-line advanced hepatocellular carcinoma treatment

被引：0
|
作者：
Wong, Jeffrey Sum Lung [1 ]
Wong, Carmen Chak-Lui [2 ]
Sun, Frances Sze Kei [1 ]
Yau, Thomas [1 ,3 ]
机构：
[1] Queen Mary Hosp, Dept Med, Hong Kong, Peoples R China
[2] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Peoples R China
[3] Univ Hong Kong, Ctr Canc Med, Hong Kong, Peoples R China
来源：
LANCET ONCOLOGY | 2025年 / 26卷 / 02期
关键词：
ATEZOLIZUMAB; BEVACIZUMAB;
D O I：
10.1016/S1470-2045(24)00728-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：152 / 153
页数：2
相关论文
共 50 条
  • [1] Drug Treatment for Advanced Hepatocellular Carcinoma: First-Line and Beyond
    Feng, Maple Ye
    Chan, Landon L.
    Chan, Stephen Lam
    CURRENT ONCOLOGY, 2022, 29 (08) : 5489 - 5507
  • [2] Considerations for individualized first-line systemic treatment in advanced hepatocellular carcinoma
    Peeters, Frederik
    Dekervel, Jeroen
    CURRENT OPINION IN PHARMACOLOGY, 2023, 70
  • [3] PHARMACOECONOMIC EVALUATION OF SORAFENIB AS FIRST-LINE TREATMENT FOR ADVANCED HEPATOCELLULAR CARCINOMA
    Naumovska, Z.
    Nestorovska, Kapedanovska A.
    Grozdanova, A.
    Suturkova, L.
    Dimovski, A.
    Sterjev, Z.
    VALUE IN HEALTH, 2017, 20 (09) : A736 - A736
  • [4] Donafenib as a first-line monotherapy for advanced hepatocellular carcinoma
    Zhang, Bo -Han
    Cai, Yun-Shi
    Jiang, Li
    Yang, Jia-Yin
    HEPATOBILIARY SURGERY AND NUTRITION, 2021, 10 (05) : 737 - 740
  • [5] Cost-effectiveness of sorafenib as a first-line treatment for advanced hepatocellular carcinoma
    Zhang, Pengfei
    Yang, Yu
    Wen, Feng
    He, Xiaofeng
    Tang, Ruilei
    Du, Zedong
    Zhou, Jing
    Zhang, Jian
    Li, Qiu
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (07) : 853 - 859
  • [6] First-line treatment for hepatocellular carcinoma: Resection or transplantation?
    Bhoori, S.
    Schiavo, M.
    Russo, A.
    Mazzaferro, V.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) : 2271 - 2273
  • [7] Sintilimab plus IBI305 as first-line treatment for advanced hepatocellular carcinoma
    Jia, F.
    Ren, Z.
    Xu, J.
    Shao, G.
    Dai, G.
    Liu, B.
    Xu, A.
    Yang, Y.
    Wang, Y.
    Zhou, H.
    Chen, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S692 - S692
  • [8] Durvalumab receives second approval for the first-line treatment of advanced or unresectable hepatocellular carcinoma
    不详
    VISCERAL MEDICINE, 2024, 40 (01)
  • [9] Optimal first-line treatment for advanced thymic carcinoma
    Yang, Xue
    Zhuo, Minglei
    Shi, Anhui
    Yang, Shengnan
    Wang, Ziping
    Wu, Meina
    An, Tongtong
    Wang, Yuyan
    Li, Jianjie
    Zhong, Jia
    Chen, Hanxiao
    Jia, Bo
    Dong, Zhi
    Zhao, Jun
    THORACIC CANCER, 2019, 10 (11) : 2081 - 2087
  • [10] Update on first-line treatment of advanced ovarian carcinoma
    Kemp, Z.
    Ledermann, J. A.
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2013, 5 : 45 - 51
12345